Working to develop an innovative therapy to treat degenerative retinal disorders.

Learn More

image of a persons eye

A revolutionary approach – jCell Therapy

jCell is a first-in-class investigational treatment in late-stage clinical development for retinitis pigmentosa (RP), and other inherited retinal and blinding diseases.

View ouR Platform

image of a scientist look through a mircoscope

Proprietary platform for multiple ophthalmic indications

jCyte is pursuing multiple drug development programs for a range of degenerative retinal disorders and optic nerve conditions, focusing on preserving and restoring vision in patients.

View ouR Pipeline

Looking for brilliant minds like you.

At jCyte, we’re passionate about developing transformative therapies to improve the lives of patients by developing best-in-class treatments for blinding diseases.

Join our Team